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the upstream rpoBF1 but with a DNA
uptake sequence (in lower case) that
was added at the 5′ end to permit
DNA transformation (7). The trans-
formant strain NM05-08 was resistant
to rifampin (MIC >32 mg/L), and the
sequence of the rpoB gene confirmed
the His→Tyr mutation. When com-
pared to the parental isolate
(LNP21362), strain NM05-08 showed
reduced virulence. Indeed, bacterial
loads were similar to those observed
for the resistant isolate LNP22330
(Figure). These results strongly sug-
gest a direct negative impact of rpoB
mutations on meningococcal viru-
lence. Mutations in the rpoB gene
have been reported to confer
pleiotropic phenotypes (8). 
The data reported here show that
rifampin-resistant isolates were not
clonal but belonged to different genet-
ic lineages. The results of virulence
assays in mice suggest that mutations
in rpoB in resistant isolates may have
a major biological cost for N. menin-
gitidis, which can be defined as lower
bacterial fitness in terms of survival in
the bloodstream. This biological cost
could explain the lack of clonal
expansion of meningococcal isolates
that acquired resistance to rifampin.
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Vaccination-related
Mycobacterium
bovis BCG Infection 
To the Editor: The high preva-
lence of tuberculosis (TB) underlines
the important role of BCG (bacillus
Calmette-Guérin) immunization. The
vaccine, however, is not free from
complications, which could be local
or disseminated. Disseminated BCG
infection as a result of TB vaccination
is a rare complication with an inci-
dence of 0.06 to 1.56 cases per million
vaccinations; it occurs exclusively in
patients with immune deficits.
However, in these cases, the progno-
sis is unfavorable; up to 70% of
patients die, despite intensive antitu-
berculous treatment (1–4).
A 4-month-old-girl exhibited
enlargement of left axillary lymph
nodes during a 1.5-month period. She
was the second child of healthy par-
ents, with no family history of genetic
disorders or TB. She was vaccinated
according to the regimen compulsory
in Poland: the first dose of BCG and
anti–hepatitis B virus (HBV) vaccina-
tion on the first day of life, followed
by vaccination against diphtheria,
tetanus, pertussis, poliomyelitis, and
the second dose of anti-HBV after 6
weeks. BCG vaccination was per-
formed intradermally in the upper part
of left arm by administration of 0.1
mL Brazilian Moreau strain (Biomed,
Lublin, Poland).
On hospital admission, the patient
was in reasonably good condition but
pale, with grossly enlarged, adjacent
left axillary lymph nodes and
hepatosplenomegaly. Laboratory tests
showed anemia, thrombocytopenia,
elevated transaminase activity, a high
C-reactive protein level, and high
level of immunoglobulin M (IgM)
class anti-cytomegalovirus (CMV)
reactive antibodies. 
Based on clinical manifestations
and biochemical and serologic signs,
CMV infection was suspected. The
patient was administered a 14-day
regimen of ganciclovir (10
mg/kg/day); results of liver function
tests and blood count normalized, and
hepatosplenomegaly decreased.
However, the lymph nodes continued
to enlarge, and diagnostic excision
and bone marrow aspiration were per-
formed to exclude a neoplastic
process. A histopathologic image of
the excised lymph nodes showed
caseating granulomas, and tubercu-
lous lymphadenitis was suggested
(Figure).
At that time, a diagnosis of dis-
seminated BCG infection as a compli-
cation of TB vaccination in a pre-
sumed immunocompromised patient
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was proposed. This idea was based on
suggestive lymph node pathology,
which showed caseating granulomas,
a history of TB vaccination, and the
exclusion of other pathologic
changes. Flow cytometry measure-
ments showed abnormally low
expression of the α chain of the inter-
feron (IFN)-γ receptor on peripheral
blood lymphocytes. Only 20% lym-
phocytes expressed CD 119 (IFN-γ
receptor outer subunit R1).
Three-drug anti-tuberculous thera-
py (with rifampin, isoniazid, and
streptomycin) was introduced despite
chest and bone radiographs that were
negative for infection, no abnormali-
ties found on funduscopy, and nega-
tive results of Ziehl-Neelsen staining
of lymph node tissue. Despite this
therapy, the child’s condition wors-
ened; she exhibited a high tempera-
ture, hemolysis, and progressive neu-
tropenia, thrombocytopenia, cholesta-
sis, and renal failure. Uncontrolled
sepsis developed, and she died.
At postmortem examination, the
diagnosis of disseminated BGC infec-
tion was made on the basis of multiple
TB-like granulomas in the lungs,
lymph nodes, meninges, liver, spleen,
and kidneys. However, direct micro-
biologic confirmation of BCG infec-
tion was lacking because cultures
were negative and Ziehl-Neelsen and
periodic acid–Schiff staining did not
show acid-fast bacilli, other bacteria,
or fungi in these specimens.
This case represents a rare compli-
cation of antituberculous vaccination,
that is a progressive, disseminated
BCG infection in a patient with defi-
ciency of IFN-γ receptor.
Concomitant CMV infection was
diagnosed by positive IgM antibody
response. Transient response to the
ganciclovir treatment made the final
diagnosis of BCG infection more dif-
ficult and probably postponed imple-
mentation of the anti-TB therapy.
Until now ≈100 cases have been
reported in the literature, most of
them in infants and young children.
These patients also had clear predis-
position to other severe infections
with intracellular microorganisms
such as atypical mycobacteria,
Salmonella spp.,  Listeria monocyto-
genes, and Leishmania spp. (1–5). 
The INF-γ receptor is present on
many cell types; however, its defi-
ciency on macrophages may be
responsible for the inhibition of
phagocytosis and intracellular killing
and the observed deficit of an antimy-
cobacterial immunity. Among chil-
dren with a clinical syndrome of IFN-
γ–receptor deficiency, a clear genetic
defect was identified in ≈20%. In our
patient, the diagnosis was made by
detection by flow cytometry of abnor-
mally low expression of the α chain
of the IFN-γ receptor on peripheral
blood lymphocytes. This method
appears to have high diagnostic value,
given the fact that genetic methods are
not always available and are expen-
sive and often insensitive. 
The prognosis in patients with
BCG infection secondary to IFN-
γ–receptor deficiency is unfavorable.
A few cases of successful treatment
with allogenic bone marrow trans-
plantation have been reported with
long-term improvement of general
condition and stable receipt of the
graft as shown by molecular analysis
of peripheral leukocytes (4,6–8).
However, as specific and efficient
therapy for this condition has not been
as yet proposed, supportive measures
with early diagnosis and institution of
anti-TB and antimicrobial drug treat-
ment appear to be important in man-
aging this rare immune deficiency.
The level of IFΝ-γ−receptor expres-
sion in populations known to be sus-
ceptible to TB, and its potential role in
this phenomenon, appears to be a
promising area of study.
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Figure. Digitally processed hematoxylin-eosin staining of the excised lymph nodes, show-
ing caseating, tuberculosislike granulomas (original magnification ×100).LETTERS
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Human Bocavirus
in Children
To the Editor: Respiratory tract
infection is a major cause of illness in
children. Despite the availability of
sensitive diagnostic methods, detect-
ing infectious agents is difficult in a
substantial proportion of respiratory
samples from children with respirato-
ry tract disease (1). This fact suggests
the existence of currently unknown
respiratory pathogens.
A new virus has been recently
identified in respiratory samples from
children with lower respiratory tract
disease in Sweden (2). Analysis of the
full-length genome sequence showed
that this virus is closely related to
bovine parvovirus and canine minute
virus and is a member of the genus
Bocavirus, subfamily Parvovirinae,
family  Parvoviridae. This virus has
been provisionally named human
Bocavirus (HBoV) (2). HBoV in res-
piratory samples from Australian chil-
dren was also recently reported (3).
Involvement of this new virus in res-
piratory tract diseases merits further
investigation. We have therefore ret-
rospectively tested for HBoV
nasopharyngeal samples collected
from children <5 years of age hospi-
talized with respiratory tract disease. 
Samples were collected from 262
children from November 1, 2003, to
January 31, 2004. The samples were
tested for respiratory viruses by using
direct immunofluorescence assays
with monoclonal antibodies to respi-
ratory syncytial virus; influenza virus
types A and B; parainfluenza virus
types 1, 2, and 3; and adenovirus.
Samples were also placed on MRC5
cell monolayers for virus isolation
and tested for human metapneu-
movirus by reverse transcription–
polymerase chain reaction (RT-PCR).
Nucleic acids were extracted from
samples, stored at –80°C, and tested
for HBoV DNA by PCR with primers
specific for the predicted NP1 gene as
previously described (2). The expect-
ed product size was 354 bp. In each
experiment, a negative control was
included, and positive samples were
confirmed by analyzing a second
sample. Amplification specificity was
verified by sequencing. 
Nine (3.4%) samples were posi-
tive. Comparison of PCR product
sequences of these 9 isolates
(GenBank accession nos. AM109958–
AM109966) showed minor differ-
ences that occurred at 1 to 4 nucleotide
positions, and a high level of sequence
identity (99%–100%) was observed
with the NP1 sequences of the previ-
ously identified ST1 and ST2 isolates
(2). This finding indicates that HBoV
is a highly conserved virus.
HBoV was the only virus identified
in 6 children and was associated with
respiratory syncytial virus in 3 other
children. An infection with other res-
piratory viruses was detected among
153 (60.5%) of the 253 HBoV-nega-
tive children. The viruses identified
were respiratory syncytial virus in 114
(43.5%) samples, human metapneu-
movirus in 27 (10.3%) samples,
influenza A virus in 14 (5.4%) sam-
ples, rhinovirus in 4 (1.5%) samples,
adenovirus in 2 (0.8%) samples, and
parainfluenza virus type 3 in 1 (0.4%)
sample. Respiratory syncytial virus
was associated with human metapneu-
movirus in 9 (3.4%) samples.
Clinical characteristics of the
HBoV-infected children are shown in
the Table. Children infected with only
HBoV had mild-to-moderate fevers.
Leukocyte counts and C-reactive pro-
tein levels were normal or moderately
elevated. Chest radiographs obtained
for 7 children showed abnormalities
such as hyperinflation and interstitial
infiltrates. Bronchiolitis was the
major diagnosis. Dyspnea, respiratory
distress, and cough were the most
common respiratory symptoms
observed. Four (44%) HBoV-infected
children were born preterm, which
suggests that these children have an
increased susceptibility to HBoV-
associated diseases. All children
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